These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24665138)

  • 21. Meningococcal vaccination for college freshmen.
    Bröker M
    Cleve Clin J Med; 2001 Oct; 68(10):879. PubMed ID: 11596625
    [No Abstract]   [Full Text] [Related]  

  • 22. Group B meningococcal vaccine: recommendations for UK use.
    Pollard AJ; Riordan A; Ramsay M
    Lancet; 2014 Mar; 383(9923):1103-4. PubMed ID: 24661533
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunisation against meningococcus B.
    Head C
    Lancet; 2013 Sep; 382(9896):935. PubMed ID: 24034290
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunisation against meningococcus B.
    Rappuoli R
    Lancet; 2013 Sep; 382(9896):935-6. PubMed ID: 24034289
    [No Abstract]   [Full Text] [Related]  

  • 25. University fresher campaign doubles meningitis vaccination rate, UK study finds.
    Mayor S
    BMJ; 2017 Jan; 356():j224. PubMed ID: 28093388
    [No Abstract]   [Full Text] [Related]  

  • 26. Vaccine evaluation: lessons from a meningococcal B vaccine.
    Sarfatti A; Martinón-Torres F; Nadel S
    Arch Dis Child; 2015 Jun; 100(6):514-6. PubMed ID: 25670403
    [No Abstract]   [Full Text] [Related]  

  • 27. How college nurses managed the meningitis C campaign.
    Halligan E
    Nurs Times; 2000 Nov 30-Dec 6; 96(48):38-9. PubMed ID: 11965995
    [No Abstract]   [Full Text] [Related]  

  • 28. New meningococcal A vaccine is being introduced into Africa.
    Mayor S
    BMJ; 2010 Nov; 341():c6736. PubMed ID: 21106620
    [No Abstract]   [Full Text] [Related]  

  • 29. Do we need a new approach to making vaccine recommendations?
    Crowcroft NS; Deeks SL; Upshur RE
    BMJ; 2015 Jan; 350():h308. PubMed ID: 25637290
    [No Abstract]   [Full Text] [Related]  

  • 30. Meningococcal conjugate vaccine updates.
    Weber AK; Hayney MS
    J Am Pharm Assoc (2003); 2012; 52(6):855-8. PubMed ID: 23229973
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of state vaccine financing policy on uptake of heptavalent pneumococcal conjugate vaccine.
    Stokley S; Shaw KM; Barker L; Santoli JM; Shefer A
    Am J Public Health; 2006 Jul; 96(7):1308-13. PubMed ID: 16735626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectious disease. Shortage of meningitis vaccine forces triage in Burkina Faso.
    Vogel G
    Science; 2003 Mar; 299(5612):1499-501. PubMed ID: 12624241
    [No Abstract]   [Full Text] [Related]  

  • 33. Toward a meningitis-free world.
    Black S; Pizza M; Nissum M; Rappuoli R
    Sci Transl Med; 2012 Feb; 4(123):123ps5. PubMed ID: 22378923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UK immunization highs and lows.
    Birmingham K
    Nat Med; 2001 Feb; 7(2):135. PubMed ID: 11175820
    [No Abstract]   [Full Text] [Related]  

  • 35. Dutch consider following UK on vaccines after meningitis scare.
    Sheldon T
    BMJ; 2001 Sep; 323(7311):470. PubMed ID: 11532831
    [No Abstract]   [Full Text] [Related]  

  • 36. Meningococcal C conjugate vaccines: UK campaign.
    Nurs Stand; 2000 Nov 8-14; 15(8):33. PubMed ID: 11971466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The multicomponent meningococcal serogroup B vaccine (4CMenB): origin, composition, health impact and unknown aspects.
    Mameli C; Galli E; Mantegazza C; Fabiano V; Zuccotti GV
    Future Microbiol; 2015; 10(10):1579-98. PubMed ID: 26437903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project.
    Aguado MT; Jodar L; Granoff D; Rabinovich R; Ceccarini C; Perkin GW
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S391-5. PubMed ID: 26553665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should we be doing more to prevent Group C meningococcal infection in school age children? How can we decide?
    Johnstone T
    J Public Health Med; 1999 Dec; 21(4):480; author reply 481. PubMed ID: 11469376
    [No Abstract]   [Full Text] [Related]  

  • 40. Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model.
    Trotter CL; Edmunds WJ
    Med Decis Making; 2006; 26(1):38-47. PubMed ID: 16495199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.